These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26973064)

  • 1. Status of vaccine research and development for Campylobacter jejuni.
    Riddle MS; Guerry P
    Vaccine; 2016 Jun; 34(26):2903-2906. PubMed ID: 26973064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.
    Maue AC; Poly F; Guerry P
    Hum Vaccin Immunother; 2014; 10(6):1499-504. PubMed ID: 24632556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Immunogenicity and Protective Efficacy of a
    Ramakrishnan A; Schumack NM; Gariepy CL; Eggleston H; Nunez G; Espinoza N; Nieto M; Castillo R; Rojas J; McCoy AJ; Beck Z; Matyas GR; Alving CR; Guerry P; Poly F; Laird RM
    mSphere; 2019 May; 4(3):. PubMed ID: 31043512
    [No Abstract]   [Full Text] [Related]  

  • 4. Campylobacter polysaccharide capsules: virulence and vaccines.
    Guerry P; Poly F; Riddle M; Maue AC; Chen YH; Monteiro MA
    Front Cell Infect Microbiol; 2012; 2():7. PubMed ID: 22919599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines against Campylobacter jejuni.
    Scott DA
    J Infect Dis; 1997 Dec; 176 Suppl 2():S183-8. PubMed ID: 9396708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory considerations for Campylobacter vaccine development.
    Kopecko DJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S189-91. PubMed ID: 9396709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni.
    Monteiro MA; Baqar S; Hall ER; Chen YH; Porter CK; Bentzel DE; Applebee L; Guerry P
    Infect Immun; 2009 Mar; 77(3):1128-36. PubMed ID: 19114545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Campylobacter vaccine development.
    Poly F; Noll AJ; Riddle MS; Porter CK
    Hum Vaccin Immunother; 2019; 15(6):1389-1400. PubMed ID: 30252591
    [No Abstract]   [Full Text] [Related]  

  • 9. Campylobacter jejuni proteomics for new travellers' diarrhoea vaccines.
    Schrotz-King P; Prokhorova TA; Nielsen PN; Crawford JS; Morsczeck C
    Travel Med Infect Dis; 2007 Mar; 5(2):106-9. PubMed ID: 17298916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a polysaccharide conjugate vaccine to reduce colonization by Campylobacter jejuni in broiler chickens.
    Hodgins DC; Barjesteh N; St Paul M; Ma Z; Monteiro MA; Sharif S
    BMC Res Notes; 2015 Jun; 8():204. PubMed ID: 26032784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The design of a capsule polysaccharide conjugate vaccine against Campylobacter jejuni serotype HS15.
    Bertolo L; Ewing CP; Maue A; Poly F; Guerry P; Monteiro MA
    Carbohydr Res; 2013 Jan; 366():45-9. PubMed ID: 23261782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.
    O'Ryan M; Vidal R; del Canto F; Carlos Salazar J; Montero D
    Hum Vaccin Immunother; 2015; 11(3):601-19. PubMed ID: 25715096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects.
    Tribble DR; Baqar S; Carmolli MP; Porter C; Pierce KK; Sadigh K; Guerry P; Larsson CJ; Rockabrand D; Ventone CH; Poly F; Lyon CE; Dakdouk S; Fingar A; Gilliland T; Daunais P; Jones E; Rymarchyk S; Huston C; Darsley M; Kirkpatrick BD
    Clin Infect Dis; 2009 Nov; 49(10):1512-9. PubMed ID: 19842970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Campylobacter jejuni virulence factors: update on emerging issues and trends.
    Tikhomirova A; McNabb ER; Petterlin L; Bellamy GL; Lin KH; Santoso CA; Daye ES; Alhaddad FM; Lee KP; Roujeinikova A
    J Biomed Sci; 2024 May; 31(1):45. PubMed ID: 38693534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Campylobacter jejuni capsular genotypes are related to Guillain-Barré syndrome.
    Heikema AP; Islam Z; Horst-Kreft D; Huizinga R; Jacobs BC; Wagenaar JA; Poly F; Guerry P; van Belkum A; Parker CT; Endtz HP
    Clin Microbiol Infect; 2015 Sep; 21(9):852.e1-9. PubMed ID: 26070960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward the Development of Glycan-Based Vaccines against Campylobacteriosis.
    Cloutier M; Gauthier C
    ACS Infect Dis; 2021 May; 7(5):969-986. PubMed ID: 32579844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and immunodetection of 6-O-methyl-phosphoramidyl-α-D-galactose: a Campylobacter jejuni antigenic determinant.
    Jiao Y; Ma Z; Ewing CP; Guerry P; Monteiro MA
    Carbohydr Res; 2015 Dec; 418():9-12. PubMed ID: 26513759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter jejuni Infections: update on emerging issues and trends.
    Allos BM
    Clin Infect Dis; 2001 Apr; 32(8):1201-6. PubMed ID: 11283810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current perceptions of travelers' diarrhea treatments and vaccines: results from a postal questionnaire survey and physician interviews.
    Miller N; Saunders I
    J Travel Med; 2007; 14(3):158-67. PubMed ID: 17437471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbe-Derived Outer Membrane Vesicles: A Potential Platform to Control Cecal Load of
    Singh A; Khan A; Ghosh T; Mondal S; Mallick AI
    ACS Infect Dis; 2021 May; 7(5):1186-1199. PubMed ID: 33724795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.